FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:216-220 January 17, 2002 Number 3

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Kulynych, J. PubMed Citation

Americans support both protecting the privacy of medical records and encouraging medical research. Thus, it is not surprising that a move to change practices in these two areas has generated attention and comment. The new federal regulations, promulgated under the authority of the Health Insurance Portability and Accountability Act of 1996 (HIPAA), were adopted to protect the privacy of medical records. They were not specifically designed to facilitate or limit medical research.¹ Nonetheless, the regulations have prompted strong objections from the biotechnology industry and from academic medicine. The Association of American Medical Colleges and the Biotechnology Industry Organization have argued . . . [Full Text of this Article]

Research Rules

Objections to the New Rules

New Authorization Requirements for the Release of Medical Information

A Broader View

Conclusions

References

Related Letters:

Medical Privacy and Medical Research
Rosenfeld C. R., Annas G. J.
Extract | Full Text | PDF  
N Engl J Med 2002; 346:1674, May 23, 2002. Correspondence

This article has been cited by other articles:

• Boyd, A. D., Saxman, P. R., Hunscher, D. A., Smith, K. A., Morris, T. D., Kaston, M., Bayoff, F., Rogers, B., Hayes, P., Rajeev, N., Kline-Rogers, E., Eagle, K., Clauw, D., Greden, J. F., Green, L. A., Athey, B. D. (2009). The University of Michigan Honest Broker: A Web-based Service for Clinical and Translational Research and Practice. J. Am. Med. Inform. Assoc. 16: 784-791 [Abstract] [Full Text]  
• Kernan, W. N., Viscoli, C. M., DeMarco, D., Mendes, B., Shrauger, K., Schindler, J. L., McVeety, J. C., Sicklick, A., Moalli, D., Greco, P., Bravata, D. M., Eisen, S., Resor, L., Sena, K., Story, D., Brass, L. M., Furie, K. L., Gutmann, L., Hinnau, E., Gorman, M., Lovejoy, A. M., Inzucchi, S. E., Young, L. H., Horwitz, R. I., On behalf of the IRIS Trial Investigators, (2009). Boosting enrollment in neurology trials with Local Identification and Outreach Networks (LIONs). Neurology 72: 1345-1351 [Abstract] [Full Text]  
• Marsh, J.L., McMaster, W., Parvizi, J., Katz, S. I., Spindler, K. (2008). AOA Symposium. Barriers (Threats) to Clinical Research. JBJS 90: 1769-1776 [Full Text]  
• Ness, R. B., for the Joint Policy Committee, Societies of Epide, (2007). Influence of the HIPAA Privacy Rule on Health Research. JAMA 298: 2164-2170 [Abstract] [Full Text]  
• McMaster, W. C., Sale, K., Andersson, G. B.J., Bostrom, M. P.G., Gebhardt, M. C., Trippel, S. B., Clark, D. C. (2006). The Conduct of Clinical Research Under the HIPAA Privacy Rule. JBJS 88: 2765-2770 [Full Text]  
• Trevena, L, Irwig, L, Barratt, A (2006). Impact of privacy legislation on the number and characteristics of people who are recruited for research: a randomised controlled trial.. J. Med. Ethics 32: 473-477 [Abstract] [Full Text]  
• Kapp, M B (2006). Ethical and legal issues in research involving human subjects: do you want a piece of me?. J. Clin. Pathol. 59: 335-339 [Abstract] [Full Text]  
• Avidan, A., Weissman, C., Sprung, C. L. (2005). Web-Based Data Collection: Security Is Only as Good as the Weakest Link. Anesth. Analg. 101: 1888-1888 [Full Text]  
• Albert, S. M., Levine, C. (2005). Family Caregiver Research and the HIPAA Factor. Gerontologist 45: 432-437 [Abstract] [Full Text]  
• Armstrong, D., Kline-Rogers, E., Jani, S. M., Goldman, E. B., Fang, J., Mukherjee, D., Nallamothu, B. K., Eagle, K. A. (2005). Potential Impact of the HIPAA Privacy Rule on Data Collection in a Registry of Patients With Acute Coronary Syndrome. Arch Intern Med 165: 1125-1129 [Abstract] [Full Text]  
• Neale, A. V., Schwartz, K. L. (2004). A Primer of the HIPAA Privacy Rule for Practice-Based Researchers. J Am Board Fam Med 17: 461-465 [Full Text]  
• Clark, D E (2004). Practical introduction to record linkage for injury research. Inj. Prev. 10: 186-191 [Abstract] [Full Text]  
• Noone, M. C., Walters, K. C., Gillespie, M. B. (2004). Research Subject Privacy Protection in Otolaryngology. Arch Otolaryngol Head Neck Surg 130: 266-269 [Abstract] [Full Text]  
• Pirzada, A., Yan, L. L., Garside, D. B., Schiffer, L., Dyer, A. R., Daviglus, M. L. (2004). Response Rates to a Questionnaire 26 Years after Baseline Examination with Minimal Interim Participant Contact and Baseline Differences between Respondents and Nonrespondents. Am J Epidemiol 159: 94-101 [Abstract] [Full Text]  
• Annas, G. J. (2003). HIPAA Regulations -- A New Era of Medical-Record Privacy?. NEJM 348: 1486-1490 [Full Text]  
• Sung, N. S., Crowley, W. F. Jr, Genel, M., Salber, P., Sandy, L., Sherwood, L. M., Johnson, S. B., Catanese, V., Tilson, H., Getz, K., Larson, E. L., Scheinberg, D., Reece, E. A., Slavkin, H., Dobs, A., Grebb, J., Martinez, R. A., Korn, A., Rimoin, D. (2003). Central Challenges Facing the National Clinical Research Enterprise. JAMA 289: 1278-1287 [Abstract] [Full Text]  
• Oakes, J. M. (2002). Risks and Wrongs in Social Science Research: An Evaluator's Guide to the IRB. Eval Rev 26: 443-479 [Abstract]  
• Rosenfeld, C. R., Annas, G. J. (2002). Medical Privacy and Medical Research. NEJM 346: 1674-1674 [Full Text]  
• Foucar, E., Annas, G. J. (2002). How Much Oversight Is Necessary to Protect Human Subjects?. JAMA 287: 716-717 [Full Text]  
• Kulynych, J., Korn, D. (2002). The Effect of the New Federal Medical-Privacy Rule on Research. NEJM 346: 201-204 [Full Text]